Asperger syndrome cost-effectiveness of therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Asperger syndrome}} | {{Asperger syndrome}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
== Overview == | |||
Based on a prevelance of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively. | |||
== Cost-Effectiveness of Therapy == | |||
Based on a prevelance of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively. | |||
==References== | ==References== | ||
Revision as of 06:22, 20 June 2020
|
Asperger Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asperger syndrome cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Asperger syndrome cost-effectiveness of therapy |
|
Risk calculators and risk factors for Asperger syndrome cost-effectiveness of therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Based on a prevelance of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively.
Cost-Effectiveness of Therapy
Based on a prevelance of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively.